Efficient construction of a diabody using a refolding system: AntiCarcinoembryonic antigen recombinant antibody fragment

被引:23
作者
Asano, R
Kudo, T
Nishimura, Y
Makabe, K
Hayashi, H
Suzuki, M
Tsumoto, K
Kumagai, I
机构
[1] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Cell Resource Ctr Biomed Res, Aoba Ku, Sendai, Miyagi 9808575, Japan
[3] Tohoku Univ, Sch Med, Dept Surg 1, Aoba Ku, Sendai, Miyagi 9808575, Japan
关键词
adoptive immunotherapy; bispecific diabody; CEA; inclusion body;
D O I
10.1093/oxfordjournals.jbchem.a003303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant fragments of the variable region of antibodies are useful in many experimental and clinical applications. However, it can be difficult to obtain these materials in soluble form after their expression in bacteria. Here, we report an efficient procedure for preparing several variable-domain fragments (Fv), single-chain Fv (scFv), and a diabody (the smallest functional bispecific antibody) of anti-carcinoembryonic antigen (CEA) antibody by overexpression in Escherichia coli in inclusion bodies, using a refolding system to obtain renatured proteins. Two types of refolded Fv were prepared: (i) Heavy and light chains of the immunoglobulin variable regions (VH and VL, respectively) were coexpressed with a dicistronic expression vector (designated Fv(co)); (ii) VH and VL were expressed separately, mixed stoichiometrically, and refolded (designated Fv(mix)). All samples refolded with high efficiency; Fv(co), Fv(mix), scFv, and the bispecific diabody bound to several CEA-positive cell lines, exactly as did soluble Fv fragments secreted by E. coli (Fv(sol)) and the parent IgG. The refolded fragments inhibited binding of the parent IgG to CEA-positive cell lines, indicating that their epitope is identical to that of IgG. The bispecific diabody, which combined variable-region fragments of anti-CEA antibody with variable-region fragments of anti-CM antibody, was also prepared using the refolding system. This refolded diabody could bind to lymphokine-activated killer cells. In addition, its cytotoxicity toward human bile duct carcinoma TFK-1 and other several other CEA-positive cell lines was concentration-dependent. Taken together, our results suggest that a refolding procedure can be used to prepare various functional antibody fragments (Fv, scFv, and diabody).
引用
收藏
页码:903 / 909
页数:7
相关论文
共 33 条
[1]   COMPARATIVE IMAGING AND BIODISTRIBUTION STUDIES WITH AN ANTI-CEA MONOCLONAL-ANTIBODY AND ITS F(AB)2 AND FAB FRAGMENTS IN MICE WITH COLON-CARCINOMA XENOGRAFTS [J].
ANDREW, SM ;
PIMM, MV ;
PERKINS, AC ;
BALDWIN, RW .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 (04) :168-175
[2]   A bispecific diabody that mediates natural killer cell cytotoxicity against xenotransplantated human Hodgkin's tumors [J].
Arndt, MAE ;
Krauss, J ;
Kipriyanov, SM ;
Pfreundschuh, M ;
Little, M .
BLOOD, 1999, 94 (08) :2562-2568
[3]   Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system [J].
Asano, R ;
Takemura, S ;
Tsumoto, K ;
Sakurai, N ;
Teramae, A ;
Ebara, S ;
Katayose, Y ;
Shinoda, M ;
Suzuki, M ;
Imai, K ;
Matsuno, S ;
Kudo, T ;
Kumagai, I .
JOURNAL OF BIOCHEMISTRY, 2000, 127 (04) :673-679
[4]   RENATURATION, PURIFICATION AND CHARACTERIZATION OF RECOMBINANT FAB-FRAGMENTS PRODUCED IN ESCHERICHIA-COLI [J].
BUCHNER, J ;
RUDOLPH, R .
BIO-TECHNOLOGY, 1991, 9 (02) :157-162
[5]   Engineering antibodies for imaging and therapy [J].
Carter, P ;
Merchant, AM .
CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (04) :449-454
[6]   Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells [J].
Cochlovius, B ;
Kipriyanov, SM ;
Stassar, MJJG ;
Christ, O ;
Schuhmacher, J ;
Strauss, G ;
Moldenhauer, G ;
Little, M .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :888-895
[7]  
Holliger P, 1999, CANCER RES, V59, P2909
[8]   DIABODIES - SMALL BIVALENT AND BISPECIFIC ANTIBODY FRAGMENTS [J].
HOLLIGER, P ;
PROSPERO, T ;
WINTER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6444-6448
[9]   PROTEIN AGGREGATION INVITRO AND INVIVO - A QUANTITATIVE MODEL OF THE KINETIC COMPETITION BETWEEN FOLDING AND AGGREGATION [J].
KIEFHABER, T ;
RUDOLPH, R ;
KOHLER, HH ;
BUCHNER, J .
BIO-TECHNOLOGY, 1991, 9 (09) :825-829
[10]   Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery [J].
Kim, JC ;
Roh, SA ;
Koo, KH ;
Ryu, JH ;
Hong, HK ;
Oh, SJ ;
Ryu, JS ;
Kim, HJ ;
Bodmer, WF .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (04) :542-547